Latest 10-Q quarterly reports

Immunocore Holdings plc announced a significant increase in revenue and a return to net income for the second quarter of 2026, driven by strong KIMMTRAK sales.

Papa John's reports a decline in Q2 2026 revenues and net income, driven by lower company-owned restaurant sales and ongoing transformation initiatives, while also announcing a suspension of its quarterly dividend.

CPI Card Group Inc. announced a 15.0% increase in revenue for the second quarter of 2026, driven by strong performance in its Secure Card Solutions segment and a recent acquisition.

Amylyx Pharmaceuticals details Q2 2026 financial performance, highlighting increased R&D and SG&A expenses, while advancing its pipeline candidates avexitide and AMX0035.

Avalo Therapeutics, Inc. announced positive Phase 2 results for abdakibart and a significant equity raise, bolstering its financial position and advancing its lead drug candidate.

Foghorn Therapeutics reports a substantial increase in collaboration revenue for Q2 2026, driven by a catch-up adjustment, while operating expenses decrease, though net losses persist.

Kenvue Inc. announced its second-quarter 2026 financial results, showcasing a 3.0% increase in net sales and a notable rise in net income, while also detailing progress and considerations related to its pending acquisition by Kimberly-Clark.

Unusual Machines, Inc. (UMAC) reported a substantial increase in revenue for the second quarter of 2026, driven by its enterprise segment and expanding manufacturing capabilities, alongside a significant improvement in net income.

Marten Transport reports a 25.7% decrease in net income for Q2 2026 compared to the prior year, driven by increased fuel costs and lower gains on equipment sales, despite a slight increase in Truckload revenue.

Insmed Incorporated's Q2 2026 Form 10-Q filing reveals a substantial increase in product revenues, primarily due to the commercial launch of BRINSUPRI, alongside continued investment in research and development.

Starwood Property Trust reported its Q2 2026 results, with revenues up year-over-year but facing increased credit loss provisions and mixed segment performance.

Via Transportation, Inc. announced its Q2 2026 financial results, showcasing a 27% year-over-year revenue increase to $135.7 million, though the company continues to report net losses.

Palladyne AI Corp. reported a significant increase in revenue for the second quarter of 2026, driven by acquisitions, but continued to incur substantial operating losses and negative cash flow.

Nuvation Bio Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing product revenue from IBTROZI, increased operating expenses, and a substantial accumulated deficit, while also announcing a significant convertible senior notes offering.

Enovis Corporation's Q2 2026 filing reveals significant revenue growth and improved gross profit margins, driven by strong performance in its Reconstructive segment and operational efficiencies.

Zai Lab reported a 3% decline in net product revenue for Q2 2026, driven by ZEJULA and VYVGART, while R&D expenses increased significantly due to licensing fees, though pipeline advancements and a new schizophrenia drug launch offer future potential.

Cognex Corporation announced a 17% year-over-year revenue increase for Q2 2026, driven by broad-based strength across key end markets and improved gross margins.

ESAB Corporation's Q2 2026 Form 10-Q reveals significant revenue increases driven by the Eddyfi acquisition and favorable currency movements, though net income from continuing operations saw a decline.

SecureTech Innovations, Inc. has amended its Q1 2026 10-Q filing to restate prior financial statements due to accounting errors and disclosed material weaknesses in internal controls, raising substantial doubt about its ability to continue as a going concern.

FS KKR Capital Corp. reported a net loss of $475 million for the six months ended June 30, 2026, a significant decrease from the prior year's net loss of $89 million, with net asset value per share declining to $18.30.

Walker & Dunlop reported a significant decline in net income for the second quarter of 2026, driven by a substantial increase in provision for credit losses and indemnified/repurchased loan expenses, despite a 9% year-over-year increase in total revenues.

Prestige Consumer Healthcare Inc. reported a 6.5% increase in total revenues for the three months ended June 30, 2026, driven by the acquisition of the OTC Wellness Business.

Blackstone Secured Lending Fund reports a decrease in net asset value per share and investment income for the six months ended June 30, 2026, while maintaining a robust liquidity position and managing a large, diversified portfolio.

Ducommun Inc. announced a significant increase in net revenues and net income for the second quarter of 2026, driven by strong performance in commercial aerospace and military/space sectors.

Haemonetics Corporation announced its first quarter fiscal year 2027 results, showcasing a 5.6% increase in net revenues to $339.4 million and a 6.7% rise in operating income, driven by strong performance in its Apheresis and MedSurg segments.

GigaCloud Technology Inc. announced significant year-over-year revenue growth of 27.6% for the second quarter of 2026, driven by its GigaCloud Marketplace and off-platform sales.

Arhaus, Inc. announced a 7.4% increase in net revenue for the three months ended June 30, 2026, driven by product demand and new showroom openings, alongside a significant improvement in gross margin.

Townsquare Media, Inc. reported a net loss for the second quarter of 2026, impacted by substantial impairment charges on FCC licenses, though digital advertising revenue showed growth.

East West Ave Acquisition Corp. has filed its quarterly report for the period ending May 31, 2026, detailing its pre-operational status, financial condition, and preparations for its initial public offering.

McEwen Inc. announced a significant increase in revenue and net income for the second quarter of 2026, driven by higher gold and silver prices and improved performance from its equity method investments.